Context Therapeutics (CNTX) Price Target Increased by 13.33% to 5.78

Average one-year price target for Context Therapeutics (CNTX) was raised to $5.78, up 13.33% from the prior $5.10 target dated Feb 21, 2026. The $5.78 figure represents the mean of analyst price targets, reflecting modestly improved analyst sentiment that may affect near-term investor positioning but is unlikely to move broader markets.

Analysis

Average one-year price target for Context Therapeutics (CNTX) was raised to $5.78, up 13.33% from the prior $5.10 target dated Feb 21, 2026. The $5.78 figure represents the mean of analyst price targets, reflecting modestly improved analyst sentiment that may affect near-term investor positioning but is unlikely to move broader markets.